Clinuvel Pharmaceuticals Limited (ASX:CUV)

Clinuvel Pharmaceuticals Revenue

Clinuvel Pharmaceuticals had revenue of 35.65M AUD in the half year ending December 31, 2024, with 21.39% growth. This brings the company's revenue in the last twelve months to 91.02M, up 11.34% year-over-year. In the fiscal year ending June 30, 2024, Clinuvel Pharmaceuticals had annual revenue of 88.18M with 12.59% growth.

• Revenue (ttm): 91.02M
• Revenue Growth: +11.34%
• P/S Ratio: 6.05
• Revenue / Employee: 5.69M
• Employees: 16
• Market Cap: 550.61M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	88.18M	9.86M	12.59%
Jun 30, 2023	78.32M	12.60M	19.17%
Jun 30, 2022	65.72M	17.40M	36.02%
Jun 30, 2021	48.32M	15.75M	48.37%
Jun 30, 2020	32.57M	1.52M	4.89%